Rxo (RXO) Non-Current Deferred Tax Liability (2021 - 2026)

Rxo (RXO) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $36.0 million the latest figure, recorded in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $36.0 million, down 53.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.0 million (down 53.25% YoY), and the FY2025 annual result was $51.0 million, down 66.67% from the prior year.
• Non-Current Deferred Tax Liability was $36.0 million for Q1 2026 at Rxo, down from $51.0 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $153.0 million in Q4 2024 and troughed at $1.0 million in Q1 2024.
• Average Non-Current Deferred Tax Liability over 5 years is $50.3 million, with a median of $43.5 million recorded in 2022.
• Year-over-year, Non-Current Deferred Tax Liability sank 93.75% in 2024 and surged 7600.0% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $43.0 million in 2022, then tumbled by 83.72% to $7.0 million in 2023, then surged by 2085.71% to $153.0 million in 2024, then sank by 66.67% to $51.0 million in 2025, then retreated by 29.41% to $36.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $36.0 million in Q1 2026, $51.0 million in Q4 2025, and $54.0 million in Q3 2025.